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Thermal stabilityTransmembrane transporters are responsible for maintaining a correct internal cellular environment. The in-
herent ﬂexibility of transporters together with their hydrophobic environment means that they are challeng-
ing to study in vitro, but recently signiﬁcant progress been made. This review will focus on in vitro stability
and folding studies of transmembrane alpha helical transporters, including reversible folding systems and
thermal denaturation. The successful re-assembly of a small number of ATP binding cassette transporters is
also described as this is a signiﬁcant step forward in terms of understanding the folding and assembly of
these more complex, multi-subunit proteins. The studies on transporters discussed here represent substan-
tial advances for membrane protein studies as well as for research into protein folding. The work demon-
strates that large ﬂexible hydrophobic proteins are within reach of in vitro folding studies, thus holding
promise for furthering knowledge on the structure, function and biogenesis of ubiquitous membrane trans-
porter families. This article is part of a Special Issue entitled: Protein Folding in Membranes.
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1.1. Folding transporters
There is currently a large imbalance in protein folding studies,with a
large body of knowledge relating to water-soluble proteins [1], whilst
the membrane protein ﬁeld remains largely a mystery. Folding studies
to date have focussed mainly on small soluble proteins [2], with very
few studies on larger, multidomain soluble proteins [3] and even
fewer on integral membrane proteins [4–6]. Those fewmembrane pro-
teins that have been studied have generally also been single domain,
relatively well behaved, stable proteins. The signiﬁcant, ubiquitous
membrane transporter families comprise large multi-domain or
multi-subunit proteins and are therefore a very under-represented
group of proteins in the folding ﬁeld. The principles of water-soluble
protein folding cannot be applied wholeheartedly to membrane pro-
teins due to the radically different environments of the twoprotein clas-
ses, where membrane proteins fold within a hydrophobic, anisotropic
environment rather than a polar, aqueous solvent. Unlike water-
soluble proteins, membrane proteins expose their hydrophobic resi-
dues to the membrane, instead of burying them in the protein interior.
In contrast hydrophilic residues are found either on the surface of the
protein outside the membrane, or neighbouring the lipid headgroups
at the membrane edges, as well as sometimes on the inside of the pro-
tein structure, for example when forming a channel. Membrane pro-
teins exist in a heterogeneous environment, interacting with lipid
chains, headgroups and aqueous phases, and are also highly inﬂuenced
by their lipid surroundings, which take an active role in topology of the
protein and its function [5].
Membrane proteins, particularly transporters and receptors, have
been the subject of many reviews [7–11]. Receptors have been stud-
ied in great detail, and are reviewed elsewhere [12]. Transporters
have a high physiological relevance and represent over a third of all
drug targets [13].The lack of information regarding transporters
means that the molecular basis of action of many drugs is unclear.
In addition, there are many diseases associated with membrane pro-
teins [8,14–16], which are often as a consequence of mutation as in
the case of cystic ﬁbrosis [17]. Disease creating mutations are often
far away from the active site [18], with an unknownmechanism of ac-
tion but frequently inﬂuencing folding, stability and trafﬁcking within
the cell. Owing to the lack of information on membrane proteins, any
further elucidation of the molecular basis of these diseases is very dif-
ﬁcult, which in turn means many therapies out currently of reach
until more information can be gained.
The current disparity in knowledge of water-soluble and mem-
brane protein folding is in part a consequence of the fact that, as
well as being more hydrophobic, membrane proteins are often
much more dynamic than soluble proteins. Such dynamic behaviour
is inherent to transport but makes membrane transporters very difﬁ-
cult to work with in vitro. In addition to this problem, membrane pro-
teins can be challenging to express and purify in sufﬁcient quantities
in vitro, as their inherent hydrophobic nature means they have a high
tendency to aggregate once removed from their native lipid environ-
ment. However, these barriers to folding research must be overcome
in order to learn about the fundamental folding properties and thus
maintain and study the correct structure and function of membrane
proteins, and therefore ultimately to learn more about their physio-
logical roles. Current folding work in vitro therefore focuses on
elucidating how to stabilise and study relatively simple, usuallyprokaryotic, membrane proteins, with the aim of extending the
knowledge gained to a wider range of physiologically relevant pro-
teins in the future. In vivo folding of helical membrane proteins
tends to involve co-translational insertion via a membrane-
embedded translocon complex. Cellular studies are thus also under-
taken, with notable examples including probing the role of lipids in
transporter topology [19] or the role of the translocon in identifying
transmembrane helices, and the order in which helices emerge from
the translocon into the bilayer [20,21]. There are also studies on β
barrel membrane proteins, as they are often comparatively easy to
express as inclusion bodies which can then be dissolved in urea [22].
Transporters often have more than one domain or even multiple
subunits, which create further difﬁculties in vitro in ensuring the cor-
rect assembly is being studied (see references [7,23] for reviews on
transporter structures). Studying multidomain and multisubunit
membrane proteins provides information on the interfaces between
different domains and subunits, and the importance of these interac-
tions in the overall stability and fold of the protein [24,25]. These in-
terface regions are particularly important as they allow the ﬂexibility
needed for transporter function. It is also important to establish
whether domains fold independently or cooperatively, as this may
shed some light on assembly of membrane proteins in vivo, and the
consequences of small alterations induced in assembly and stability
by mutations.
1.2. Detergent or lipid?
In addition to the heterogeneous environment surrounding mem-
brane proteins, there is the added complexity in that membranes in
different cellular locations contain very different lipid compositions
(for a review on these see reference [26]). It is becoming increasingly
obvious that these diverse lipid compositions are important, with cer-
tain speciﬁc lipids being essential for correct protein function, topol-
ogy, and overall fold [19,27]. There have been extensive reviews on
the effect of lipids on the topology of secondary transporters
[19,28,29]. There are other examples where the exact molecular
mechanism of these lipid effects on transporters is unclear, with evi-
dence varying as to whether these are due to bulk lipid effects [30–
32], or speciﬁc interactions between the lipid and the protein [33].
Several studies show that the lipid curvature and lateral pressure in
the bilayer alter the membrane insertion kinetics and folding rates
of membrane proteins [30–32,34,35]. It is therefore important to con-
sider these lipid effects for the protein in question, and whether the
absence of, or an incorrect, lipid inﬂuence would create artefactual
results.
The complex native membrane protein environment is challeng-
ing to reproduce and thus folding is studied in a simpler system in
vitro. During puriﬁcation, membrane proteins are usually puriﬁed
into detergents or lipid vesicles, or liposomes, as a mimic of the
lipid bilayer. The validity of this is obviously questionable, but simpler
systems must ﬁrst be used in order to gain sufﬁcient information to
move forward successfully to a more complex and realistic artiﬁcial
system. Many in vitro membrane protein folding studies use deter-
gent micelles, however the lack of curvature stress in micelles could
alter the stability or structure of the protein [6]. Nonetheless the de-
tergent micelles used in vitro provide a convenient and practical solu-
tion for membrane protein study and in numerous cases can sustain a
stable, functional protein structure, highlighted in a recent review
by Sanders and Mittendorf, which argues the case for using model
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mologous membrane proteins across all organisms, and the differing
lipid compositions experienced by a single membrane protein in
its lifetime, both suggest that while the lipid environment is very
important, membrane proteins clearly have a high tolerance for the
surrounding membrane's composition. This is also illustrated by the
fact that in vitro studies using different model membrane systems
give similar results [36]. Therefore in vitro studies using non-
physiological model membrane systems can still be highly useful.
1.3. Membrane protein folding in vitro and mechanistic models
Several models and hypotheses have been proposed for the fold-
ing mechanisms of alpha helices within the membrane, as outlined
below.
The classic two stage model for folding was originally outlined in
1990 by Popot and Engleman [37]. This model is based on thermody-
namic principles, and whilst being oversimplistic, has nonetheless
often provided a useful framework for transmembrane helical pro-
teins. The two-stage model is based upon the principle that trans-
membrane helices can be inherently stable, thus in stage one helices
insert into the membrane, whilst in stage two they rearrange to
form their native interhelical contacts and tertiary structure. This
model is generally insufﬁcient to explain transporter folding, espe-
cially in cases where there is more than one domain or subunit fold-
ing cooperatively. The two stage model was modiﬁed in 2003 to
include a third stage [38], which could involve any number of events
including higher order domain association, the binding of a prosthetic
group, or the folding of extramembrane loops after insertion. This
three stage model still contains the assumption that individual helices
are stable independently. Equally, however, some transmembrane
helices are often not stable entities, for example if they contain sever-
al polar amino acids, and there are cases where certain helices require
the existence of a pre-formed helical bundle in the membrane to in-
sert and fold.
The proposal that interactions between several helices occur in a
single second step most certainly masks a number of smaller steps
necessary to form these interactions. The early stage of α helical in-
teractions within the membrane is thought to involve minor docking
events, with few speciﬁc interactions between side chains, and little
or no change in the degree of solvent bound to the structure [39]. A
later folding stage would involve the formation of stabilising contacts,
where helices come together and the solvent is forced away due to
the higher stability of the helical contacts. Loops may be the ﬁnal
parts to fold, after being brought together by the helices, which can
act as an initial scaffold.
This review will focus on the stability and folding of transporters,
and will brieﬂy discuss different mechanistic models for folding, then
summarise the results from in vitro stability studies and the effects of
varying lipid composition on stability. Some examples of the effects of
mutation on folding and stability will also be discussed with respectTable 1
Expression and puriﬁcation systems for transporters.
Family Transporter Chromatograpy Detergent solu
MFS GalP C terminal 6-His tag, Ni2+-NTA DDM solubilis
DDM/liposom
LacY Biotin/Avidin DM
GLUT1
SMR EmrE 6-His/Ni2+-NTA followed by
gel ﬁltration
DDM
ATPase CopA Puriﬁed at 4 °C with C terminal
6-His tag, Ni2+-NTA
C12E10 solub
DDM/asolectin
PTS IImtl 6-His tag puriﬁed by Ni2+-NTA Decyl-PEG sol
DM exchange
DMPC for exp
The puriﬁcation systems used for some of the transporters discussed in this review.to a variety of different families of transporter. We will commence
with an overview of experimental approaches that are commonly
applied in studies of transporter folding and stability.
2. Methods to study transporters in vitro
2.1. Techniques to measure folding and activity
The unavoidable presence of detergents and lipids in membrane
protein samples increases the difﬁculty of in vitro work, due to the
high level of scattering in spectroscopic methods, which can create
artefacts in measurements [4,18]. The presence of lipids or detergent
also creates a highly anisotropic environment, and in addition the
usually relatively low quantities of protein make data interpretation
difﬁcult due to a low signal to noise ratio, and the high likelihood
of artefacts in the data. Often there are only very small differences be-
tween the folded and unfolded state [18], which further adds to the
signal vs. noise problem. The method of expression and puriﬁcation
of alpha helical membrane proteins is very important, as most mem-
brane proteins have a high tendency to form insoluble aggregates
when overexpressed, giving low yields (see reference [40] for a
review on this subject). Table 1 gives an overview of the expression
and puriﬁcation methods of the transporters discussed in this review.
A novel method to measure a high afﬁnity association of helices
within the bilayer is to use a steric trap. The association of Glyco-
phorin A helices has been measured using this method, a biotin ac-
ceptor peptide was fused to Glycophorin A, and the binding of
streptavidin (mSA) was used to measure the dissociation constants
of helix association. The binding sites for mSA can be engineered in
such a way so that only one mSA can bind if Glycophorin A is a
dimer due to steric clashing, therefore the binding parameters of
mSA can be used to elucidate the dissociation constant of the dimer.
This method has the advantage in that it enables the measurement
of a high afﬁnity association without the need to dilute the complex,
which is usually necessary to dissociate high afﬁnity interactions. This
is an important tool for the investigation of multidomain membrane
complexes, and to compare the stability of the complex in different
systems. For example in this study, the dimer was much more stable
in POPC bilayers than in detergent micelles [41].
2.2. Reversible and irreversible folding experiments
There are several methods to study folding in vitro. A folding reac-
tion measured at equilibrium is fully microscopically reversible, i.e.
removing the denaturant is sufﬁcient for full refolding back to the na-
tive state, and equilibrium unfolding and refolding curves will overlay
as folding and unfolding reactions follow the same pathway. Denatur-
ation can be either chemical or thermal; therefore reversibility would
involve either removing a chemical denaturant, for example by dialy-
sis or dilution, or decreasing the temperature for thermal studies.
Membrane transporters often unfold irreversibly by thermalbilisation and experiments Problems encountered? Reference
ed
es (DOPE/DOPC 60 mol% PE)
[43,92]
Aggregation during refolding [44]
6-His tag interferes with
dimer formation
[34,35]
ilised Some detergents give
inactive protein
[42,76]
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eriments
[25]
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C Keq = Fraction Folded
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D              GU = -RT ln Keq
Fig. 1. Determination of unfolding free energy from a denaturation curve. In an unfolding experiment the amount of native protein structure is measured, for example by ﬂuores-
cence or CD, at increasing concentrations of denaturant. The change in the amount of folded structure is then plotted against the denaturant concentration, giving a denaturation
curve (A). Refolding curves are measured in the same way, by diluting the denaturant. If the folding and unfolding curves overlay, then it is a two state reaction, and the fraction of
folded and unfolded protein can be calculated at each denaturant concentration. From this, the equilibrium constant (Keq) can be calculated (see the equation in C), and free energy
of unfolding (ΔGU) can be calculated (see the equation in D) at each denaturant concentration, which is then plotted (B). The linear ﬁt of these points can then be extrapolated to
zero denaturant, which gives the free energy of unfolding in the absence of denaturant, ΔGUH2O.
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denaturation however, can often be reversible [34,42–44] (see Fig. 1).
The reduction in native protein structure induced during titration
with denaturant is measured to produce a denaturation curve,
which for an equilibrium reaction can be exactly overlaid by the
refolding curve, during which the denaturant is diluted. An equilibri-
um constant, K, can be measured for both the forward and reverse re-
actions (unfolding and refolding respectively), and the associated free
energy of folding or unfolding, ΔG, can be calculated.
Unfolding can be fully reversible, but with a different reaction
pathway for unfolding and folding. This would happen for example
when lipids have been added after the removal of denaturant toReversible folding at equilibriu
unfolding are via the same pathw
values to be determined
Add denaturant
R d
Folded
emove 
Reversible folding via a
unfolding is fully reversible, b
folding reactions occur via differe
Remove denaturan
Irreversible denaturati
denaturant does not allo
Add den 
Fig. 2. Reversible and irreversible folding. Different types of in vitro folding reactions, revers
in the middle and irreversible folding at the bottom. Denaturant is shown as red circles, wit
have not been shown for clarity.promote refolding. No thermodynamic equilibrium information can
be gained from these sorts of folding reactions, but it is useful as a
measure of stability for investigating the effects of varying the lipid
composition on refolding [31,32,34,35,43]. See Fig. 2 for a comparison
of reversible folding at equilibrium, and reversible folding via a sepa-
rate folding pathway.
Thermal denaturation can often be ﬁt to a reaction schemewith an
initial, reversible equilibrium folding step up to a certain tempera-
ture, and a subsequent irreversible step at higher temperatures.
Thus, thermodynamic can still be obtained. In the case of membrane
proteins, lipids and detergent properties change at different tempera-
tures, which also affect the stability and the results seen.m: folding and 
Unfolded
ay, allowing K and G 
t tena uran
different pathway:
ut the unfolding and
nt pathways
Unfolded
/aggregated
t, add lipids
on: removal of 
w refolding
aturant
ible folding at equilibrium is shown at the top, reversible folding via different pathways
h the location of the denaturant around the protein approximated. Detergents or lipids
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One of the earliest methods applied to probe transporter stability
was thermal denaturation. The enthalpy of a protein is usually affect-
ed by temperature, and increases with increased temperature [45].
The method of choice is Differential Scanning Calorimetry (DSC), a
highly sensitive technique giving quantitative thermodynamic infor-
mation [46–48]. DSC involves comparing the heat generated by a
sample in comparison to a reference cell at different temperatures.
Detailed thermodynamic information can be gained via this method,
including the temperature at which transitions occur (Tm), and the
heat capacity of these transitions (Cp). The calorimetric enthalpy,
ΔHcal, can be determined directly obtained from a DSC experiment
from the area under the heat absorption peak in the thermogram
and is expressed on a molar basis. It is often useful to also determine
the van't Hoff enthalpy, for which an effective equilibrium constant is
deﬁned, based on the progress of the reaction as obtained from the
transition curve. However, this analysis is only valid if the sample is
in thermodynamic equilibrium throughout the experiment. This is
shown by the fact that the transition is reversible (as determined in
a rescan of the sample) and independent of the scanning rate used
in the experiment, which shows that the reaction is not under kinetic
control. Although this is rarely the case for membrane proteins, this
technique has been particularly useful for multidomain membrane
proteins, as it gives insight into the interactions between different do-
mains [25,46]. Data for most membrane proteins is ﬁt to a model in-
volving a reversible reaction followed by irreversible denaturation.
There are many problems associated with measuring the thermo-
dynamic parameters of alpha helical membrane protein thermal de-
naturation. The detergent or lipid used and its effects are important
to consider, as the interactions with the protein are likely to be affect-
ed at different temperatures. Phase transitions of the detergent or
lipid can also occur, creating artefacts in the results. The altered inter-
actions between the solvent and the detergent can also prevent the
protein from being soluble, leading to aggregation during the experi-
ment. Membrane transporter unfolding by thermal denaturation is
usually only reversible up to a certain temperature, therefore irre-
versible transitions make DSC experiments and the subsequent data
interpretation difﬁcult, it is also fairly common to be unable to get
replicable results. There have however been a few examples of
alpha helical membrane proteins investigated in this way, most
have been receptors and photosystems [46], but there have been aTable 2
Reversible folding methods.
Family Transporter How it was unfolded, and
how it was measured
How it was re
ABC Vitamin B12
transporter
(BtuCD)
Unfolded in urea
Measured by ﬂuorescence, CD and
loss of ATPase activity
Bound to Ni2+
and eluted int
MFS GalP Unfolded in urea or GuHCl
Measured by ﬂuorescence, CD or
loss of ligand binding
Dilution into D
liposomes
Lactose
Permease
(LacY)
Unfolded in GuHCl
Measured by MIANS ﬂuorescence
and substrate protection
Dialysis into D
of 3:1 POPE/P
SMR EmrE Unfolded in 10 M urea plus 5% or 10% SDS
Measured by ﬂuorescence, CD
and cysteine labelling
Either by dilu
binding to Ni2
and eluted int
ATPase CopA Unfolded in 8 M GuHCl
Measured by ﬂuorescence, CD and
loss of transport activity
Dilution into D
asolectin
Na+/H+
antiporter
NhaA Unfolded by AFM Helices reinse
spontaneously
The conditions and methods used for reversible folding of transporters, and how this reversib
while not strictly a two state reversible folding study, the re-assembly was speciﬁcally invesmall number of transporters also, as explained in greater detail in
Section 3 [25,45,47,48].
2.4. Reversible folding
The establishment of a two-state (or three-state) folding reaction
in vitro greatly facilitates a complete understanding of folding, includ-
ing thermodynamic stability. An experimental system is required in
which a microscopically reversible folding reaction is observed at
equilibrium. This is frequently established for helical membrane pro-
teins using chemical denaturants such as urea or SDS, and renaturing
micelles. Kinetic measurements have been used to conﬁrm two-state
equilibrium folding between unfolded and refolded states [49].
There are only a handful of transporters for which reversible fold-
ing has been successful. These come from several different families of
transporter, and are summarised in Table 2. Brieﬂy, these are the
Major Facilitator Superfamily galactose and lactose transporters
GalP and LacY [43,44], the Small Multidrug Resistance transporter
EmrE [34], the thermophilic copper ATPase CopA [42], and the Na+/
H+ antiporter NhaA [50]. These have been expressed and puriﬁed
using a variety of methods using different detergents, and unfolded
with different denaturants. As previous folding studies to date had
been conﬁned to small soluble proteins or single domain, experimen-
tally amenable, helical membrane proteins and β barrels, these more
recent studies on transmembrane α helical transporters represent a
major step forward in the folding ﬁeld.
2.5. A brief note on denaturants
SDS is a common denaturant used for α helical proteins, with sev-
eral theories proposed for its denaturant action [39,51], whilst con-
versely it has been found to stabilise and induce helical structure
[52]. SDS maintains a micellar environment by forming mixed mi-
celles with the renaturing detergent in the system. Morever, although
SDS causes reductions in tertiary structure and loss of function, at best
it only causes partial reductions in helicity of transmembrane pro-
teins and sometimes the native α helical content is maintained [53].
As a result, the unfolded state created by SDS contains signiﬁcant he-
lical structure (see Fig. 3). For more detailed information on the inter-
actions between SDS and membrane proteins, see references [54,55].
Fully unfolded states of helical membrane proteins require strongfolded How was the return of
function demonstrated?
What did we learn? Reference
-NTA column
o DDM
Correct oligomeric state by
gel ﬁltration and SDS-PAGE,
return of ATPase activity
More efﬁcient
re-assembly from
unfolded subunits
[24]
DM or into Return of ligand binding
and transport
Liposome composition
affects refold yield
[43]
M in presence
OPG
Return of substrate
protection against
thermal denaturation
Presence of TDG did
not accelerate
refolding
[44]
tion or by
+-NTA column
o DDM
Return of TPP binding
measured by ITC
Liposome composition
affects refold yield
[34]
DM and Return of transport
function
Unfolded state present
undetected by
spectroscopic methods
[42]
rted Not done Helices are associated
in pairs
[50]
ility and return of function was demonstrated. BtuCD has been included in this table, as
stigated from both unfolded and folded subunits.
Folded Unfolded
Water 
soluble 
protein
Random coilAdd denaturant
Remove denaturant
Outer 
membrane 
beta barrel
Random coil
Add denaturant
Remove denaturant
Integral High proportion of 
residual helicity
Add denaturant
Remove denaturant
 
alpha helical 
membrane 
protein
Fig. 3. Reversible unfolding of proteins. Alpha helical membrane proteins have a lot of residual helical structure remaining when reversibly unfolded, unlike β barrels and water
soluble proteins which tend to unfold into a more random coil-like structure. Denaturant is shown as red circles, with the positions of the denaturant around each protein approx-
imated. The denaturant is not necessarily the same for each protein. Detergents or lipids have not been shown around the β barrel and alpha helical proteins for clarity (PDB IDs
1B2X, 2BRD, 1THQ).
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or lipids, since they also destabilise these latter structures.
Chaotrope denaturants such as urea and guanidine hydrochloride
(GuHCl) may preferentially bind to the unfolded state, stabilising it
over the folded state, and altering the folding equilibrium. These de-
naturants may also solvate charged residues, or directly hydrogen
bond with the backbone, disrupting native interactions [56]. This is
a different mechanism of action from that proposed for SDS denatur-
ation, thus limiting direct comparisons between these two methods
of unfolding in that SDS can readily partition into micelles and desta-
bilise lipid bilayers, whilst urea and GuHCl do not. Urea does, howev-
er, alter the dynamics and phase behaviour of detergents and lipids,
for example by a change in the detergent critical micelle concentra-
tion. The relative inability of urea to denature micelles or bilayers
means it often cannot denature helical membrane proteins, although
in acidic conditions — as is the case for diacylglycerol kinase (DGK) —
quaternary trimer interactions are perturbed in micelles but little
helix reduction occurs. Urea can also denature aqueous extrinsic re-
gions of helical membrane proteins. The ﬂexibility of transporters
with hydrophilic binding pockets may also provide access for urea
into the protein interior for denaturation. Urea is however an effec-
tive denaturant for β barrel proteins, as seen in Fig. 3 [22].
2.6. What is the unfolded state?
The denatured state of a folding reaction is not a single state, but
an ensemble of multiple unfolded conformations [19,42], all with
many long range interactions still present. Therefore the unfolded
state measured experimentally is an average representative state of
this ensemble, so speciﬁc structural information is difﬁcult to access.
α helical membrane proteins tend to aggregate when unfolded.
Moreover, as described in Section 2.5 and shown in Fig. 3, there is a
considerable amount of structure remaining in the experimental un-
folded state, in contrast with β barrels and water-soluble proteins
[4,5]. This partly structured unfolded state may provide a critical he-
lical core that is required as a scaffold for successful folding [5]. This
is perhaps more physiologically relevant than a folding study from a
completely denatured state, as a helical membrane protein is neverin a completely random coil in vivo since they are translated directly
into the translocon, and the helices are subsequently inserted lateral-
ly into the bilayer from the translocon [20,57].
3. Families of transporters
There are several examples of transporters which have been stud-
ied in vitro for stability and folding, both by irreversible thermal dena-
turation and reversible systems. These are summarised in Table 3,
along with the methods applied to each transporter.
3.1. Major Facilitator Superfamily
The Major Facilitator Superfamily (MFS) is a very large group of
transporters found in all organisms and is responsible for transporting
a large range of substrates such as sugars, amino acids and peptides
[9,10]. There are now several high resolution crystal structures, for a
range of members and in different conformations with both bound
and unbound ligand [58–62]. Each has a very similar structure, with
12 transmembrane helices divided into two helical domains and a
large central cavity between them. There have been extensive studies
into the transport mechanism of this family [63–65], the location and
contacts within the substrate binding sites [61,62,66,67], and speciﬁc
lipid effects on function [19,33], but only a handful of studies on stabil-
ity as outlined below.
An MFS member to be investigated by thermal denaturation is the
facilitative glucose transporter GLUT1, using DSC. Thermal denatur-
ation of GLUT1 is irreversible, as demonstrated by the lack of struc-
ture when the sample was cooled. It was found that the GLUT1
substrate D-glucose speciﬁcally stabilises the protein, increasing the
Tm of 68.5 °C to 72.6 °C. It is thought that substrate binds to the
folded state and stabilises it, shifting the equilibrium between the
folded and unfolded states. The calorimetric transition enthalpy was
comparable with other membrane proteins, at 2.8 cal/g [45].
The only two state reversible unfolding study to date of an MFS
member is on the Escherichia coli galactose transporter, GalP [43]. Re-
versible folding in urea was measured at equilibrium, with intrinsic
tryptophan ﬂuorescence indicating the exposure of tryptophan
Table 3
Summary of stability studies on transporters.
Family Protein Method Results Reference
MFS GalP Reversible folding by ﬂuorescence and CD Two state free energy of unfolding
Effects of lipid composition on folding and insertion
[43]
Lactose Permease (LacY) Reversible folding by ﬂuorescence Demonstration of folding reversibility [44]
Glucose transporter 1 (GLUT1) Thermal denaturation by DSC Substrate binding increases thermal stability [45]
SMR EmrE Reversible folding by ﬂuorescence and
with lipids, ligand binding measured by ITC
Demonstration of folding reversibility
Effects of lipid composition on folding and insertion
[34]
ATPases CopA Reversible folding by ﬂuorescence and CD Reversible system and free energy [42]
NaK-ATPase Thermal denaturation by DSC Thermal stability [48]
Ca-ATPase Thermal denaturation by DSC Thermal stability [47]
ABC Histidine permease (HisQMP2) Re-assembly of subunits Non-cooperative assembly of subunits [86]
Maltose transporter (MalFGK2) Re-assembly of subunits Cooperative assembly of subunits [87]
Arginine transporter (Art(MP)2) Re-assembly of subunits Assembly of subunits [88]
Vitamin B12 transporter (BtuCD) Re-assembly of subunits from
folded and unfolded states
Cooperative assembly of subunits [24]
Na+/H+ antiporter NhaA Reversible folding measured by AFM Demonstration of folding reversibility [50]
PTS Mannitol Permease (IImtl) Thermal denaturation by DSC Interactions of domains and contribution to stability [25]
AE Anion Exchanger 1 (AE1) Thermal denaturation by DSC Interactions of domains and contribution to stability [46]
A summary table of all the transporters discussed in this review, what was measured, and the important ﬁndings from each.
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Fluorescence studies on GalP are complicated to interpret however,
due to the large number of tryptophans in a range of different envi-
ronments. A more useful technique in this case is to monitor the re-
duction in secondary structure that is induced by urea through the
use of circular dichroism (CD) spectroscopy. The free energy of
unfolding in the absence of denaturant, ΔGUH2O, was found to be
2.5 kcal/mol ±0.2 kcal/mol, with a linear dependence on denaturant.
GalP has also been found to partially refold from 3.5 M GuHCl, a much
harsher denaturant.
As discussed above, it is thought that urea is able to denature mem-
bers of theMFS due to the large proportion of solvent accessible areas in
comparison to other membrane proteins. There is currently no crystal
structure for GalP, but it is thought to be similar to GlpT and as all the
MFS structures solved thus far are very similar, it is likely that GalP
also has large solvent exposed ends of helices and a large hydrophilic
cavity that will allow access of the urea to large areas of the protein.
The most well characterised MFS member, Lactose Permease
(LacY) has also been successfully refolded after denaturation in
3.5 M GuHCl [44], with the denaturant removed by dialysis into rena-
turing dodecylmaltoside (DDM), in the presence of the lipids palmi-
toyloleoyl phosphatidylethanolamine (POPE) and palmitoyloleoyl
phosphatidylglycerol (POPG). The reversibility and recovery of func-
tion after refolding were demonstrated by a return of the substrate
TDG protecting LacY from thermal denaturation, in a manner similar
to GLUT1 as discussed above. It was necessary for refolding of LacY
to be done at a very low protein concentration (0.05 mg/ml), in
order to prevent aggregation during refolding.
LacY is well known for being very tolerant of mutations [68], with
only six residues absolutely irreplaceable for transport activity. There
is however an interesting example of how a single point mutation can
have unexpected large consequences on transport activity and stabil-
ity. The LacY C154G mutation is completely folded and able to bind li-
gand, but has highly impaired transport function. It is also much more
thermally and chemically stable in comparison to the wild type [69].
It is believed, but still unclear, that altered packing interactions be-
tween helices account for this increased stability [70].
The effects of varying lipid composition on topology, stability and
activity have been investigated for several members of the MFS with
some very interesting ﬁndings. Most of the topology studies have
been on LacY, where it has been found that when in vivo, and when
reconstituted into bilayers in vitro, the topology is severely affected
by the absence of the lipid PE, in that the entire N domain assumes
an inverted topology. It is thought that this drastic topology change
is not necessarily due to a speciﬁc requirement for PE, but is due to
the high amount of negatively charged headgroups in the bilayerthat would be the result of an absence of PE. This high negative charge
of the bilayer may disrupt the “positive inside rule” and the normal
topogenesis signals, causing an inversion of N domain topology.
Nonetheless, this inverted LacY is still folded and able to catalyse
downhill transport (see references [19,28,29] for detailed discussion
on the effects of PE on transporter topology). To date, there is no ev-
idence of an inverted topology when detergent micelles are used in-
stead of lipid vesicles. In addition, the Lactococcus lactis multidrug
MFS antiporter LmrP, which uses the proton gradient to transport cy-
totoxic compounds out of the cell, is an example of the requirement of
a speciﬁc interaction between a transporter and lipid headgroups for
correct function [71]. Hydrogen bonding with the lipid headgroup
seems to be necessary for transporter function, although the exact
mechanism is unclear [33]. The effects of varying lipid compositions
on GalP folding and insertion have also been investigated. Refolding
into liposomes has an optimum composition of 60 mol% DOPE, but
is around 2.5 times less active when in this manner in comparison
to when directly reconstituted into liposomes [43].
3.2. Na+/H+ antiporters
Themaintenance of an internal cellular pH, and the homeostasis of
sodium ion concentration is essential for cell viability. This is the role
of Na+/H+ antiporters, and there are many homologues found across
all organisms [11]. The most well characterised Na+/H+ antiporter,
the E. coli NhaA, was unfolded by Atomic Force Microscopy (AFM).
AFM uses a stylus attached to either the N or C terminal end of the
protein, with an increasing force applied to sequentially unfold indi-
vidual helices. This method has the advantage in that it can be done
on single transporters embedded in membranes. The NhaA unfolding
results showed that the transmembrane helices unfolded two at a
time, suggesting that they are associated in pairs. It was also found
that the whole protein is required to form native interactions. Unfold-
ing of NhaA by AFM was reversible, as shown when the polypeptide
chain was relaxed and the helices spontaneously re-insert (“snap
in”) in an immediate refolding step, followed by a slower refolding
step of the remaining helices [50].
3.3. Phosphoenolpyruvate dependent phosphotransferase system
The phosphoenolpyruvate dependent phosphotransferase system
(PTS) couples transport and phosphorylation of substrates, using
phosphoenolpyruvate (PEP) as the energy source to overcome the
substrate concentration gradient. The transporters in this system are
known as enzyme II, and one of its members, mannitol permease
(IImtl), has been studied by DSC. This transporter, like the other
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toplasmic phosphorylation domains, so DSC can give information on
the interactions between the domains as well as their thermal stabil-
ity. The constituent domains were expressed separately and their sta-
bility compared with that of the complete transporter. There was
more than one calorimetric transition seen in the full transporter,
with the cytoplasmic domains being responsible for the reversible
transitions at around 60 °C, and the transmembrane domain being at-
tributed to the irreversible transition at 76 °C. The Tm of the trans-
membrane domain decreases when the B cytoplasmic domain is not
present, indicating that association is necessary for stability. The calo-
rimetric transition enthalpy of 4.2 cal/g was found to be slightly
higher than other membrane proteins investigated in this way [46],
thought to be due to the degree of solvent exposure [25].
3.4. Anion exchangers
Anion Exchanger 1 (AE1), or Band 3, is a chloride-bicarbonate
antiporter mainly found in eukaryotes [72], with a transmembrane
domain and large cytoplasmic domains which interact with other cel-
lular proteins and the cytoskeleton. The stability and domain interac-
tions of AE1 have been studied by DSC, with the different domains
giving separate peaks in calorimetric thermograms. The cytoplasmic
domain transition was found to be pH dependent, with a Tm of
72 °C at pH6, and a Tm of 55 °C at pH8. The transmembrane domain
transition was between 66 and 68 °C, with the calorimetric transition
enthalpy varying depending on whether peripheral proteins were
present [46], indicating that interactions with other proteins affect
the stability of AE1. An early study of AE1 found that the membrane
spanning domain is much more resistant than the cytoplasmic do-
main to GuHCl denaturation when measured by CD, as at 4 M
GuHCl the cytoplasmic domain unfolded to a random coil, and the
membrane spanning domain retained around 70% of its helical con-
tent. This further illustrates the notion that membrane spanning re-
gions of proteins are more resistant to denaturation [73].
3.5. Small Multidrug Resistance Family
The Small Multidrug Resistance Family (SMR) is a subgroup of the
Drug/Metabolite Transporter Superfamily. The members of the SMR
family have four transmembrane helices, and function as dimers
[74]. Some reversible refolding work has been done on the SMR trans-
porter EmrE [34], which functions as a homodimer. EmrE exchanges
two protons for a substrate, which is usually hydrophobic and cation-
ic, but the transporter has a broad speciﬁcity and broad range for sub-
strates. EmrE has very stable helices, with only a small amount of
structure loss when denatured in a combination of 10 M urea and
5% SDS. From this EmrE can be refolded into both DDM micelles and
lipid vesicles. CD has been used to monitor the loss of secondary
structure, and ﬂuorescence for the degree of tryptophan exposure.
The loss of helix when unfolded is small and unquantiﬁable due to
the high amount of urea, but it is believed that urea disrupts the
dimer, as it has been found to be monomeric when visualised by
SDS-PAGE.
EmrE has also been investigated in liposomes of different compo-
sitions, to elucidate the effects of different lipids on refolding and in-
sertion efﬁciencies. It has been found that there is lower transport
activity in bilayers of higher curvature stress, as seen by increasing
the dioleoylethanolamine (DOPE) content in DOPE/dioleoylphospha-
tidylcholine (DOPC) liposomes [34,35].
3.6. Transmembrane ATPases
Transmembrane ATPases are transporters which use the hydroly-
sis of ATP as an energy source to transport substrates against their
concentration gradient [8]. There are several types of ATPase,classiﬁed by the types of substrate they transport, with a high diver-
sity in structure and oligomeric state between each transporter [16].
There are examples of P-Type ATPases which have been investi-
gated by DSC, being the sarcoplasmic reticulum Ca2+-ATPase and
the Na+, K+-ATPase [47,48]. In these studies the protein used was
isolated from native membranes, therefore the data is difﬁcult to
compare with other studies due to the lower purity of the sample.
CopA is a thermophilic alpha helical P-Type ATPase, which trans-
ports Cu+ in Archaeglobus fulgidus. It belongs to the PIB-Type ATPase
family responsible for transporting heavy metals [75], and has an op-
timum transport activity at a temperature of 75 °C [42,76]. Mixed mi-
celles of DDM and asolectin were used to unfold CopA in GuHCl. The
change in tryptophan ﬂuorescence was used to monitor the changes
in tertiary structure, and the change in CD used to monitor the de-
crease in secondary structure. Unfolding was achieved through incu-
bation in GuHCl for 2 h, with no further reduction in structure
occurring if incubated overnight. CopA was refolded by dilution into
renaturing micelles of DDM and asolectin. During unfolding the func-
tion of CopA was measured at each denaturant concentration, show-
ing a loss of activity before any structural differences could be
detected. This shows the existence an early unfolding state not
detected spectroscopically, suggesting that a two state model is not
applicable to the unfolding of this protein under the experimental
conditions.
CopAwas successfully refolded from 7.5 MGuHCl, showing a higher
stability than the members of the MFS which are reversible only up to
3.5 M [43,44]. This higher stability could be due to its nature as a ther-
mophilic protein. Nevertheless, the ΔGUH2O of 3 kcal/mol is still roughly
of the same magnitude as GalP [43]. Similarly to the MFS transporters,
CopA is accessible to water soluble chaotropes, and it also has a large
extramembrane domain which may or may not account for the major-
ity of structure loss seen.
3.7. ATP binding cassette transporters
Most membrane protein folding studies to date have focussed on
monomeric proteins. A large number of membrane proteins however
have multiple subunits, both within the membrane and in the peri-
plasm or cytoplasm. ABC (ATP Binding Cassette) transporters are a
class of transmembrane ATPase, and are a ubiquitous group of multi-
subunit membrane proteins responsible for transporting a range of
substrates either into or out of the cell with the hydrolysis of ATP.
They generally have two transmembrane domains, and two nucleo-
tide binding domains in the cytoplasm (see reference [77] for a re-
view on ABC transporters), and require molecular chaperones for
their correct assembly in the membrane [78]. Prokaryotic ABC im-
porters also have a periplasmic substrate binding protein associated
with the complex, to deliver substrate for transport. Folding studies
on ABC transporters are complicated by the possibility of cooperative
interactions between the multiple subunits [24], and is almost cer-
tainly not as simple as a two state process, due to the necessity of
the different subunits having to interact with each other.
The Cystic Fibrosis Transmembrane conductance Regulator (CFTR)
is perhaps the most well known ABC transporter, and the most well
known example of how a small mutation can have devastating conse-
quences to transporter function. CFTR is a eukaryotic chloride ion
channel gated by the hydrolysis of ATP. Like other eukaryotic ABC
transporters, it is formed of two halves, each of these composed of a
transmembrane spanning domain (TMD) and a nucleotide binding
domain (NBD). There is also a cytoplasmic regulatory domain, R,
which contains serine residues for regulation by phosphorylation.
There are many cystic ﬁbrosis causing mutations in this R domain,
often leading to trafﬁcking defects [79]. However, the mutation re-
sponsible for over 90% of cystic ﬁbrosis cases is ΔF508 in NBD1,
which lies at the interface between NBD1 and intracellular loop 4
(ICL4) of TMD2 [17].
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folding of NBD1, both in vitro and in vivo [80], not due to the loss of side
chain interactions but due to the deletion of backbone. This has been
shown by the lack of an effect on isolated NBD folding caused by mis-
sensemutations [81,82].ΔF508may slightly slow the rate of folding, al-
tering the equilibriumof chaperone binding and therefore causingmore
of it to be degraded by cellular quality control mechanisms [17]. Larger
downstreameffects on assembly due toΔF508may also occur, as the in-
teraction of NBD1 with ICL4 is altered by this deletion [17], and the
TMDs are not as stable in the bilayer when the NBDs are absent [81].
Themissensemutationswhich did not affect NBD1 foldingwhen in iso-
lation were shown to lower the amount of mature full length CFTR, il-
lustrating the importance of F508 interacting with ICL4 [81]. The
ΔF508 mutation illustrates how general domain packing and domain
interactions rather than speciﬁc residue effects are important, which
is demonstrated by the ability of suppressor mutations in sites away
from F508 partially reversing the folding defects of ΔF508 [17,80].
The bacterial homologue of CFTR, Yor1p, has several destabilising
mutations, including an analogous ΔF deletion. It has been found
that two suppressor mutations (F270S and R1168M) correct many
of these mutations, and enable the protein to avoid the quality control
machinery of the cell. These mutations do not directly correct folding
defects, but it is thought instead that due to their location near the
transmembrane domain, that they alter helix packing and bilayer in-
sertion, giving some extra tolerance for the original mutation [83].
The mechanisms of why this should be are not understood, and high-
light the need for further understanding of interactions between heli-
ces within the membrane.
Like other transporters, ABC transporter function is affected by the
presence of speciﬁc lipids. HorA is an ABC multidrug transporter of
Lactobacillus brevis, and has been found to require the presence of
the native lipid PE for transport. When HorA was reconstituted into
liposomes containing DOPC instead of DOPE, HorA was still able to ca-
talyse ATP hydrolysis, but lost the ability to transport the substrate
Hoechst 33342. In this case the lipid effects are thought to be the
more general bulk properties of PE affecting transport function and
orientation of transmembrane helices, as detected by Attenuated
Total Reﬂection-Fourier Transform Infrared Spectroscopy (ATR-FTIR)
[84]. Another ABC transporter affected by general bulk lipid effects
is the yeast Candida albicans multidrug transporter Cdr1p, with a
higher ﬂippase activity recorded bilayers of increased ﬂuidity, but a
corresponding lower transport activity [85].Table 4
Puriﬁcation, expression and re-assembly of ABC transporters.
Transporter ABC Type System for
overexpression
Extraction of NBD
from TMD
Re-assembly
His permease
(HisQMP2)
Type I E. coli TA1889 NBD HisP extracted
with 15 mM
ATP,15 mM MgSO4,
6.6 M urea
Subunits mix
30 min and c
re-assembled
pellets with l
Maltose
transporter
(MalFGK2)
Type I E. coli BL21(DE3) NBD MalK extracted
with 4–6 M urea
TMD subunit
attached to a
column, only
subunit MalK
Arginine
transporter
(Art(MP)2)
Type I E. coli Rosetta2 for TMD
ArtM (22 °C overnight)
E. coli Rosetta for
NBD ArtP (37 °C)
Subunits expressed
separately
Tagless TMD
NBD ArtP inc
4 °C for 12 h
to TALON res
of any unbou
Vitamin B12
transporter
(BtuCD)
Type II E. coli BL21 (DE3)
(20 °C induction)
NBD BtuD extracted
with 3 M urea
Tagless NBD
TMD BtuC inc
30 min on ice
by binding to
column and e
Overexpression and re-assembly conditions for the Type I ABC transporters HisQMP2, MalFG
with a poly His tag. The “extraction of NBD from TMD” column gives details on the separati
transporter.3.8. Re-assembly of ABC transporters
There are a few examples of ABC transporters which have been re-
assembled in vitro, in order to learn about the speciﬁc interactions be-
tween subunits, and to gain insight into assembly of these large com-
plexes within the cell. Re-assembly requires the individual expression
of each subunit, or failing this, the removal of subunits from each
other once expressed as a whole. These subunits are then tested for
a lack of transport activity, to demonstrate the requirement of a cor-
rectly re-assembled complex for activity. The activity is then demon-
strated to have returned once the subunits are mixed together and re-
assembled. Table 4 gives the re-assembly conditions for those that
have been re-assembled successfully in vitro. These re-assembly stud-
ies differ from the folding studies already discussed, as shown in
Fig. 4, in that they often start from prefolded subunits (with the
exception of BtuCD, [24]), and are not reversible systems.
The Type I ABC transporters Histidine Permease (HisQMP2) [86],
the Maltose Transporter (MalFGK2) [87], and the thermophilic
Arginine Transporter (Art(MP)2) [88] have all been re-assembled in
vitro, with slightly different ﬁndings from each study. HisQMP2 was
found to be uncooperative in assembly, with the two soluble NBD
subunits recruited separately [86]. In contrast, the recruitment of
the two NBDs was found to be highly cooperative in MalFGK2 [87].
In both these transporters it was necessary to express the entire com-
plex, and remove the NBDs with urea during puriﬁcation, indicating
the need for interactions between the TMDs and NBDs in vivo for
the correct fold. In contrast however, the subunits in the transporter
Art(MP)2 were expressed entirely separately, and re-assembled
without aggregation problems [88].
To date, the only Type II ABC importer that has been used in a
refolding and re-assembly study is the E. coli vitamin B12 transporter
BtuCD. The re-assembly of BtuCD was investigated from starting
states both unfolded and refolded, with the results indicating that
the most efﬁcient transporter re-assembly occurs when the subunits
have been partially unfolded prior to re-assembly, indicating some
cooperativity in folding and assembly. The results also indicated
that hydrophobic interdomain contacts increase the likelihood of co-
operative folding between subunits, perhaps explaining cooperativity
has not been observed during folding of all ABC transporters studied
[24].
The ability for each of these ABC transporters to re-assemble in
vitro from separate components illustrates that assembly does notLipid or detergent used What problems were
encountered?
Reference
ed on ice for
entrifuged,
complex
iposomes
Solubilised with OG and
E. coli lipids
Subunit HisP has a high
aggregation tendency
[86]
MalFG
Co2+,
NBD
binds
Complex solubilised in DDM,
PC liposomes used for
transport assays
Aggregation of MalFG if
expressed separately
[87]
ArtM and
ubated at
and reapplied
in for removal
nd ArtP
Complex solubilised in DS,
DDM used for re-assembly
Liposomes used for transport
assays using Geobacillus
stearothermophilus total lipids
ArtM does not stain
well, giving inaccurate
quantiﬁcation of
re-assembly
[88]
BtuD and
ubated for
, followed
Ni2+ -NTA
lution
BtuCD solubilised in LDAO,
exchanged into DDM
during puriﬁcation
Aggregation of subunit
BtuC if expressed
separately
[24]
K2, Art(MP)2, and Type II BtuCD. All of the ABC transporters in the table were puriﬁed
on of the NBD and TMD subunits from each other if they were expressed as a complete
Add denaturant
Remove denaturant
Native, assembled Non-native unfolded or 
protein or complexdisassembled protein
Folded subunits mixed 
together at the correct ratios
Fig. 4. The difference between re-assembly and refolding. The reaction at the top shows a reversible folding system, with the unfolded and folded states at either end of the folding
equilibrium, and the denaturant shown as red circles. The reaction at the bottom shows the re-assembly of a multisubunit protein from individual subunits. Re-assembly and
disassembly occur via different pathways under different conditions, with no denaturant involved.
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There in some variation however in whether or not there is coopera-
tivity in assembly, with each giving different results. BtuCD and
MalFGK2 are highly cooperative in assembly, whereas there is no ev-
idence for it with HisQMP2. These different results between illustrate
the need for more information on ABC transporters before generalisa-
tions and patterns emerge in their folding behaviour.
4. Comparison of transporter stability with other
membrane proteins
A common feature of the thermal denaturation studies discussed
in Section 3 is that the transmembrane regions of the transporters
have a higher Tm than the cytoplasmic domains [25,45,46]. The
higher stability of transmembrane regions is thought to be due to
their environment in the lipid bilayer shielding the helices, although
this does depend on the system used in the experiment.
While there are only few examples of transporters and two state
folding reactions, there are also only a handful of examples of other
membrane proteins that have been characterised in terms of the
free energy of folding. These include bacteriorhodopsin (bR, 20 kcal/
mol,[51]), diacylglycerol kinase (DGK, 16 kcal/mol, [53]), the potassi-
um channel KcsA (30.5 kcal/mol, [89]), disulphide bond reducing pro-
tein DsbB (4.4 kcal/mol, [90]), the β barrel outer membrane protein
PagP (14.3 kcal/mol, [91]) as well the transporters CopA (3 kcal/mol,
[42]) and MFS GalP (2.5 kcal/mol, [43]). Interestingly, most of these
former examples are similar to soluble proteins, in that the free ener-
gy stability is proportional to the size of the protein, as in smaller pro-
teins are less stable due to less small stabilising forces and vice versa.
The ΔGUH2O for small soluble proteins has been found to be around
0.06 kcal/mol/residue [49], with a few membrane proteins, for exam-
ple bR (+0.08 kcal/mol [49]), DGK (+0.13 kcal/mol, [53]), and PagP
(+0.09 kcal/mol, [91]) following this trend. However, the trans-
porters CopA and GalP have very low values of 0.004 kcal/mol [42]
and 0.005 kcal/mol [43] respectively, suggesting that this linear rela-
tionship with size is not always the case. These lower per residue sta-
bility values more likely reﬂect the fact there is much more ﬂexibility
and solvent exposure in these two than in the average membrane
protein, giving more accessibility to denaturant. The ΔGUH2O is perhaps
more related to exposed surface area than to the actual size of the
protein. It should also be noted that although all above values ofΔGUH2O are obtained via extrapolation of a linear free energy relation-
ship to zero denaturant and thus are in principle comparable, they
relate to different detergent/lipid folding systems as well as different
degrees of residual structure induced by different denaturants (e.g.
urea or SDS).
Determining the kinetics of a reaction is particularly important, as
it is the essential piece of information needed to understand the
mechanism of any reaction, and gives information on the transition
state of the reaction. There are only three cases where a full kinetic
analysis of reversible folding has been measured for a membrane pro-
tein; the β barrel outer membrane protein PagP [91], and theα helical
proteins bR [51] and DsbB [39], all of which are stable one domain
proteins. The kinetics of a ﬂexible multidomain or multisubunit pro-
tein would therefore signiﬁcantly advance the membrane protein
folding ﬁeld.
5. Conclusions
Folding studies of integral membrane proteins have become well
established since the pioneering work of Khorana, Engelman and
others in the 1980s on bR. Investigations into larger, ﬂexible trans-
porters are now coming of age. In spite of the renowned challenges
of hydrophobic membrane proteins, these transporter studies are
also forging new ground in folding studies in general, through inves-
tigations of intricate, dynamic multidomain and multisubunit protein
assemblies. Major experimental obstacles have been overcome, most
notably in reversible folding reactions of transporters and the deter-
mination of folding free energies. This paves the way for further fun-
damental studies on transporter folding. Nonetheless, signiﬁcant
barriers remain to be overcome that will require intensive work and
novel approaches if investigations are to progress to lipid bilayers
and beyond to cellular and misfolding studies.
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